Abiopharma

Clinical trial NCT05622708 updates: 1. completion date: 2028-06-13 → 2028-04-04 2. primary completion date: 2028-04-19 → 2028-02-08

Clinical trial NCT07124078: start date: 2026-05-31 → 2026-05-20.

Clinical trial NCT06842056: start date: 2025-03-15 → 2027-04-01.

Clinical trial NCT07580898 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-07 → 2026-06-05

Clinical trial NCT06015295 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 20 → 3 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07059845: enrollment: 320 → 400 participants.

Clinical trial NCT05505175: enrollment: 120 → 121 participants.

Clinical trial NCT06429436 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-06-30 → 2026-02-28

Conference call to review the financial statements for the first quarter of 2026 on June 3, 2026 at 13:00

Clinical trial NCT07312851 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-19 → 2026-06-11 3. primary completion date: 2026-06-19 → 2026-06-11 4. enrollment: 186 → 179 participants 5. enrollment type: ESTIMATED → ACTUAL